Go to the list of all blogs
John Y White's Avatar
published in Blogs
Sep 25, 2026
Advanced Micro Devices (AMD) Climbs +30.8% Over 30 Days as Market Cap Tops $1 Trillion

Advanced Micro Devices (AMD) Climbs +30.8% Over 30 Days as Market Cap Tops $1 Trillion

Key Takeaways

  • Advanced Micro Devices shares climbed roughly 30.8% over the trailing 30 days, from a close of $480.93 on August 26 to $629.26 on September 24, 2026.
  • The advance pushed AMD's market capitalization above $1 trillion for the first time, making it the fourth U.S. chipmaker to cross that milestone.
  • The move was fueled by strengthening AI data-center demand, record semiconductor export data, and bullish analyst commentary on EPYC processors and Instinct accelerators.
  • Second-quarter results showed revenue up 50% year over year, with data-center revenue more than doubling to $6.7 billion.
  • Valuation has expanded sharply, raising expectations ahead of AMD's next quarterly report.

AMD's Role in High-Performance Computing

Advanced Micro Devices designs high-performance computing and graphics products used across data centers, personal computers, and embedded systems. Its portfolio includes EPYC server processors, Ryzen consumer and commercial CPUs, Instinct AI accelerators, Radeon graphics cards, and adaptive and embedded chips from its Xilinx acquisition. AMD competes directly with Nvidia (NVDA) in AI accelerators and with Intel (INTC) in the x86 processor market. I follow AMD closely because of its position as a primary alternative supplier of AI compute to major cloud and hyperscale customers, a segment that has become the company's dominant growth engine. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Performance Over the Past 30 Days and Quarter

Over the last 30 days, AMD rallied from a closing price of $480.93 on August 26, 2026, to $629.26 on September 24, 2026, a gain of approximately 30.8%. The move accelerated in the final two weeks of the period, when shares rose from the low $500s to a record close above $629.

The broader quarter has been more volatile. From a close near $533 at the end of June, AMD has gained roughly 18% through late September. That net advance masked a sharp intra-quarter drawdown: shares slid about 26% from their late-June peak near $581 into a late-July trough near $430 before staging a powerful recovery. The result is a strongly positive but uneven three-month trend, with the most recent gains concentrated in September.

Drivers Behind the Recent 30-Day Advance

The recent surge reflected a combination of AI-demand signals and positive analyst activity. South Korean exports for the first 20 days of September reached a record, driven by stronger chip shipments, reinforcing expectations of sustained AI infrastructure spending. Cloud provider Nebius said it planned to raise prices for AMD EPYC Genoa computing capacity by 25%, a sign of tight supply and firm demand. Piper Sandler reiterated an Overweight rating, citing demand that continues to outstrip supply, while Stifel reiterated a Buy rating, pointing to confidence in AMD's server CPU lineup.

Sentiment also improved as Meta Platforms (META) gained traction with its Muse AI agent, prompting investors to reassess demand for server CPUs needed to support agent-based workloads. The momentum culminated on September 21, when AMD closed above $615 and its market value crossed $1 trillion for the first time.

Quarterly Performance and Fundamental Backing

AMD's quarterly performance was anchored by strong fundamentals even as the stock experienced a mid-summer pullback. On August 4, the company reported second-quarter revenue of $11.54 billion, up 50% year over year, with data-center revenue rising 107% to $6.7 billion and representing roughly 58% of total sales. Non-GAAP diluted earnings per share of $1.66 topped consensus estimates. Despite the beat, shares initially pulled back as some investors had priced in even more aggressive guidance.

The subsequent recovery was supported by AMD's expanding AI platform strategy. At its Advancing AI event, the company introduced its Helios rack-scale architecture, and it has disclosed multi-year AI deployment agreements with Meta and OpenAI of up to 6 gigawatts each, with Anthropic up to 2 gigawatts. Oracle (ORCL) also ordered 50,000 next-generation Instinct MI450 accelerators. CEO Lisa Su has told investors the company expects data-center revenue to more than double by 2027, reinforcing the long-term growth narrative behind the rebound.

What to Watch Ahead of the Next Earnings Report

AMD's next earnings report is scheduled for November 3, 2026. Management guided for third-quarter revenue of about $13 billion, implying roughly 41% year-over-year growth, with continued momentum expected from data-center products and the Helios platform. Investors will be watching whether data-center revenue growth remains above 100% and whether gross margins hold near 56%.

Beyond earnings, key factors include the pace of deployment of announced gigawatt-scale AI agreements, competitive pressure from Nvidia and custom silicon, supply constraints on server CPUs, and the broader trajectory of AI infrastructure spending. With the stock trading at a substantially elevated forward price-to-earnings multiple, execution against these expectations will be central to whether the rally can be sustained.

Integrating AI Tools Into My Research Routine

One tool I find particularly useful for this kind of analysis is Tickeron’s AI Trading Bots. It allows me to monitor signals across strategies and timeframes while I focus on the broader fundamentals and news flow. The platform helps surface relevant bots that have shown recent results, giving another layer of perspective on how automated approaches are performing on names like this.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMD

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


Momentum Indicator for AMD turns positive, indicating new upward trend

AMD saw its Momentum Indicator move above the 0 level on September 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 62 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AMD just turned positive on September 04, 2026. Looking at past instances where AMD's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.

AMD moved above its 50-day moving average on September 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AMD crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Following a +11.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMD advanced for three days, in 242 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

AMD broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AMD entered a downward trend on September 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. AMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 70 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.291) is normal, around the industry mean (7.892). P/E Ratio (160.526) is within average values for comparable stocks, (159.553). Projected Growth (PEG Ratio) (0.641) is also within normal values, averaging (3.726). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (20.450) is also within normal values, averaging (44.558).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 215.16B. The market cap for tickers in the group ranges from 86.8K to 5.49T. NVDA holds the highest valuation in this group at 5.49T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 7%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 65%. IMOS experienced the highest price growth at 27%, while MOBX experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 52
Price Growth Rating: 44
SMR Rating: 72
Profit Risk Rating: 73
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
AMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of integrated circuits for semiconductors

Industry Semiconductors

Industry
Semiconductors
Address
2485 Augustine Drive
Phone
+1 408 749-4000
Employees
31000
Web
https://www.amd.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Advanced Micro Devices (AMD) Climbs +30.8% Over 30 Days as Market Cap Tops $1 Trillion